![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1586739
¼¼°èÀÇ ¿µ»ó À¯µµ Ä¡·á ½ÃÀå(2024-2029³â)Image-guided Therapy Market, Global, 2024-2029 |
Àúħ½ÀÀû ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ¿Ü·¡È¯ÀÚ ½Ã¼³¿¡¼ ´çÀÏ ¼ö¼úÀÌ ±ÞÁõÇÏ¸é¼ Çõ½ÅÀû ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.
¿µ»óÀ¯µµÄ¡·á(IGT) ½ÃÀåÀº Àúħ½ÀÀû Ä¡·á¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡, ¸ÖƼ¸ð´Þ ¿µ»óÁø´Ü ±â¼ú ¹ßÀü, ÀΰøÁö´É, ´õ ³ªÀº ÀÓ»ó°á°ú¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀÇ »ç¿ë, ¾Ï Ä¡·á¿¡¼ Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä·Î ÀÎÇØ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, IGT ½ÃÀåÀº Á¾¾çÇÐ, ½ÉÀåÇÐ, ½Å°æ¿Ü°ú, Á¤Çü¿Ü°ú, ºñ´¢±â°ú ½Ã¼ú¿¡¼ MRI, CT, ºÐÀÚ ¿µ»ó, ÃÊÀ½ÆÄ, ÁßÀçÀû ¿¢½º·¹ÀÌÀÇ ±â¼ú Çõ½ÅÀÇ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ¾Õ¼ ¾ð±ÞÇÑ ÀÇ·á ¿µ»ó Áø´Ü ¾ç½Ä°ú ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ ¹× ·Îº¿ °øÇÐÀÇ ÅëÇÕÀº ¿Ü°ú ¼ö¼ú¿¡¼ ´õ ³ôÀº Á¤¹Ðµµ¿Í Á¤È®¼ºÀ» °¡´ÉÇÏ°Ô Çß½À´Ï´Ù.
Frost & SullivanÀº IGT°¡ ÇâÈÄ 5³â°£ ¾ÈÁ¤ÀûÀÎ ¼ºÀå¼¼¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖÀ¸¸ç, ±× ¿øµ¿·ÂÀº ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÁöÃâ°ú ÅõÀÚ Áõ°¡·Î ÀÎÇÑ °ÍÀ¸·Î º¸°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Frost & SullivanÀº ÃÖ¼Òħ½À ¼ö¼úÀÌ ±âÁ¸ ¼ö¼úº¸´Ù ³ôÀº º¸±Þ·üÀ» º¸À̸ç IGT ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.
¿¬±¸ ±â°£Àº 2022-2029³â, ±âÁØ ¿¬µµ´Â 2024³â, ¿¹Ãø ±â°£Àº 2025-2029³âÀÔ´Ï´Ù. ÀÌ º¸°í¼´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç ¹× ±âŸ ¼¼°è ½ÃÀåÀ» ºÐ¼®ÇÏ¿© ÇöÀç ½Ã³ª¸®¿À, ÃËÁø ¹× ¾ïÁ¦¿äÀÎ, Ãֽбâ¼ú, ÁÖ¸ñÇÒ ¸¸ÇÑ ÁøÃâ±â¾÷¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù.
Frost & SullivanÀº IGT ½ÃÀåÀ» ´ÙÀ½°ú °°Àº ¹üÁÖ·Î ºÐ·ùÇÕ´Ï´Ù: - Á¦Ç° À¯Çü: ÀÚº» Àåºñ - ÀÇ·á±â±â ¹× ¼Ò¸ðǰ - ¼Ö·ç¼Ç - ÀÓ»ó ÀÀ¿ë ºÐ¾ß: Á¾¾çÇÐ, ½ÉÀ庴ÇÐ, ½Å°æ¿Ü°ú, ºñ´¢±â°ú, Á¤Çü¿Ü°ú
Increased Demand for Minimally Invasive Procedures and the Surge in Day Surgeries at Outpatient Facilities are Driving Transformational Growth
The image-guided therapy (IGT) market is growing rapidly, mainly driven by the rising preference for minimally invasive procedures, technological advancements in multimodal imaging, artificial intelligence, the use of software solutions that enable better clinical outcomes, and the high demand for precision medicine in oncology treatment. In addition, the IGT market is influenced by technological innovations in MRI, CT, molecular imaging, ultrasound, and interventional X-ray during oncology, cardiology, neurosurgery, orthopedic, and urology procedures. The integration of the aforementioned medical imaging modalities with navigation systems and robotics has enabled higher precision and accuracy during surgical procedures.
Frost & Sullivan expects IGT to sustain steady growth during the next 5 years, fueled by increasing expenditures and investments in research and development that drive market expansion. Frost & Sullivan also expects minimally invasive procedures to see higher adoption than conventional surgical procedures, which will propel IGT market growth.
The study period is from 2022 to 2029, the base year is 2024, and the forecast period is from 2025 to 2029. The study analyzes the North American, European, Asia-Pacific, and Rest of World markets, focusing on current scenarios, drivers and restraints, the latest technologies, and notable participants.
Frost & Sullivan segments the IGT market into the following categories: - Product type: - Capital equipment - Medical devices and consumables - Solutions - Clinical applications: oncology, cardiology, neurosurgery, urology, and orthopedics